BIOMAT Database Logo BIOMAT Database Logo

[Surface-active properties and composition of pulmonary surfactant in patients with diseases of the bronchopulmonary system]. 1983

E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg

UI MeSH Term Description Entries
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[Surface-active properties of pulmonary surfactant in experimental pulmonary tuberculosis].
January 1975, Terapevticheskii arkhiv,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[Pulmonary surface-active factor (surfactant) in respiratory tract diseases].
August 1975, Sovetskaia meditsina,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
Surface properties, morphology and protein composition of pulmonary surfactant subtypes.
December 1996, The Biochemical journal,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases.
May 1992, Pediatric pulmonology,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[Physiopathology and clinical aspects of the alveolar surface active system (pulmonary surfactant)].
August 1977, Minerva medica,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
Bovine pulmonary surfactant: chemical composition and physical properties.
August 1983, Lipids,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[Various surface chemical properties of pulmonary surfactant].
July 1971, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[The pulmonary surface active system].
October 1971, Die Medizinische Welt,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[Alveolar surface forces and composition of the pulmonary surfactant in experimental silicosis].
January 1971, Internationales Archiv fur Arbeitsmedizin,
E N Nesterov, and G V Kobozev, and L G Safronova, and V A Sheleg
[Status of the surface-active properties of surfactant in bronchial asthma].
April 1984, Klinicheskaia meditsina,
Copied contents to your clipboard!